Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LISA: Levonorgestrel Intrauterine System in Anemic Women
NCT05233956Active, not recruiting
- Sponsor
- FHI 360
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of avatrombopag in anemia (2 arms), sponsored by FHI 360. Primary endpoint: Hemoglobin Level at 12 months. Started Oct 2023; status: active, not recruiting.
02
Drugs
avatrombopag
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05233956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05233956.